Showing results (1311-1320 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|May 16, 2018
The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic reviewYimeng Wang, Naomi Lewin, Yazan Qaoud, et al.
Breast (Edinburgh, Scotland)|June 30, 2018
The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancerCourtney R Smith, Anna M Chiarelli, Claire Mb Holloway, et al.
Breast (Edinburgh, Scotland)|July 15, 2018
Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomesWaqar Haque, Vivek Verma, Sandra Hatch, et al.
Breast (Edinburgh, Scotland)|January 15, 2010
Punch biopsy: a useful adjunct in a rapid diagnosis breast clinicB N Modi, J T Machin, D Ravichandran
Breast (Edinburgh, Scotland)|January 16, 2010
Freehand versus ultrasound-guided core biopsies of the breast: reducing the burden of repeat biopsies in patients presenting to the breast clinicS T Ward, J A Shepherd, H Khalil
Breast (Edinburgh, Scotland)|August 30, 2016
Therapeutic attitude towards internal mammary chain drainage in patients with breast cancerKarla Ferreres García, Jaime Siegrist Ridruejo, Patricia Rincón Olbés, et al.
Breast (Edinburgh, Scotland)|May 6, 2017
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)Gilles Houvenaeghel, Eric Lambaudie, Monique Cohen, et al.
Breast (Edinburgh, Scotland)|May 21, 2017
MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesionMichelle Nadler, Hyder Al-Attar, Ellen Warner, et al.
Breast (Edinburgh, Scotland)|May 4, 2017
Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trialAmal Ghouadni, Suzette Delaloge, Pilar Lardelli, et al.
Breast (Edinburgh, Scotland)|July 3, 2017
Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)Lironne Wein, Sherene Loi
Pageof 366